Alnylam Pharmaceuticals shares owned by Ensign Peak Advisors
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Ensign Peak Advisors
from 13F filings
Historical chart of Ensign Peak Advisors investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by Ensign Peak Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $31M | 68k | 456.00 |
| 2025-06-30 | $33M | 100k | 326.09 |
| 2025-03-31 | $22M | 81k | 270.02 |
| 2024-12-31 | $18M | 77k | 235.31 |
| 2024-09-30 | $22M | 81k | 275.03 |
| 2024-06-30 | $18M | 74k | 243.00 |
| 2024-03-31 | $12M | 82k | 149.45 |
| 2023-09-30 | $11M | 59k | 177.10 |
| 2023-06-30 | $9.0M | 47k | 189.94 |
| 2023-03-31 | $7.9M | 40k | 200.32 |
| 2022-12-31 | $8.8M | 37k | 237.65 |
| 2022-09-30 | $7.1M | 36k | 200.14 |
| 2022-06-30 | $5.4M | 37k | 145.83 |
| 2022-03-31 | $5.9M | 36k | 163.27 |
| 2021-12-31 | $6.9M | 41k | 169.60 |
| 2021-09-30 | $32M | 169k | 188.81 |
| 2021-06-30 | $29M | 173k | 169.52 |
| 2021-03-31 | $24M | 168k | 141.19 |
| 2020-12-31 | $14M | 110k | 129.96 |
| 2020-09-30 | $17M | 113k | 145.60 |
| 2020-06-30 | $11M | 76k | 148.10 |
| 2020-03-31 | $4.3M | 40k | 108.87 |
| 2019-12-31 | $540k | 4.7k | 115.11 |